4//SEC Filing
CoLucid Pharmaceuticals, Inc. 4
Accession 0000911916-16-000658
CIK 0001348649operating
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:45 PM ET
Size
7.1 KB
Accession
0000911916-16-000658
Insider Transaction Report
Form 4
Mathers Thomas P.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2016-09-14$23.30/sh−5,700$132,812→ 244,714 total - Sale
Common Stock
2016-09-14$23.78/sh−300$7,134→ 244,414 total
Footnotes (3)
- [F1]Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Mathers on August 19, 2016.
- [F2]Represents the sale of 5,700 shares in multiple transactions, ranging in price from $22.73 to $23.72 per share, resulting in a weighted average sale price of $23.3004. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F3]Represents the sale of 300 shares in multiple transactions, ranging in price from $23.77 to $23.79 per share, resulting in a weighted average sale price of $23.78. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
Documents
Issuer
CoLucid Pharmaceuticals, Inc.
CIK 0001348649
Entity typeoperating
Related Parties
1- filerCIK 0001348649
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:45 PM ET
- Size
- 7.1 KB